202 related articles for article (PubMed ID: 25062639)
21. Ub-ISAP: a streamlined UNIX pipeline for mining unique viral vector integration sites from next generation sequencing data.
Kamboj A; Hallwirth CV; Alexander IE; McCowage GB; Kramer B
BMC Bioinformatics; 2017 Jun; 18(1):305. PubMed ID: 28623888
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the clonal repertoire of gene-corrected cells in gene therapy.
Paruzynski A; Glimm H; Schmidt M; Kalle Cv
Methods Enzymol; 2012; 507():59-87. PubMed ID: 22365769
[TBL] [Abstract][Full Text] [Related]
23. VISA--Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing.
Hocum JD; Battrell LR; Maynard R; Adair JE; Beard BC; Rawlings DJ; Kiem HP; Miller DG; Trobridge GD
BMC Bioinformatics; 2015 Jul; 16(1):212. PubMed ID: 26150117
[TBL] [Abstract][Full Text] [Related]
24. Parachuting in the epigenome: the biology of gene vector insertion profiles in the context of clinical trials.
Baum C
EMBO Mol Med; 2011 Feb; 3(2):75-7. PubMed ID: 21254403
[TBL] [Abstract][Full Text] [Related]
25. Retroviral integration profiles: their determinants and implications for gene therapy.
Lim KI
BMB Rep; 2012 Apr; 45(4):207-12. PubMed ID: 22531129
[TBL] [Abstract][Full Text] [Related]
26. Integration site and clonal expansion in human chronic retroviral infection and gene therapy.
Niederer HA; Bangham CR
Viruses; 2014 Oct; 6(11):4140-64. PubMed ID: 25365582
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.
Arens A; Appelt JU; Bartholomae CC; Gabriel R; Paruzynski A; Gustafson D; Cartier N; Aubourg P; Deichmann A; Glimm H; von Kalle C; Schmidt M
Hum Gene Ther Methods; 2012 Apr; 23(2):111-8. PubMed ID: 22559057
[TBL] [Abstract][Full Text] [Related]
28. High-Throughput Mapping and Clonal Quantification of Retroviral Integration Sites.
Gillet NA; Melamed A; Bangham CR
Methods Mol Biol; 2017; 1582():127-141. PubMed ID: 28357667
[TBL] [Abstract][Full Text] [Related]
29. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
30. Cellular barcoding tool for clonal analysis in the hematopoietic system.
Gerrits A; Dykstra B; Kalmykowa OJ; Klauke K; Verovskaya E; Broekhuis MJ; de Haan G; Bystrykh LV
Blood; 2010 Apr; 115(13):2610-8. PubMed ID: 20093403
[TBL] [Abstract][Full Text] [Related]
31. Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.
Biasco L
Hum Gene Ther; 2017 Dec; 28(12):1122-1129. PubMed ID: 29160103
[TBL] [Abstract][Full Text] [Related]
32. A retroviral vector common integration site between leupaxin and zinc finger protein 91 (ZFP91) observed in baboon hematopoietic repopulating cells.
Kiem HP; Ironside C; Beard BC; Trobridge GD
Exp Hematol; 2010 Sep; 38(9):819-22, 822.e1-3. PubMed ID: 20434516
[TBL] [Abstract][Full Text] [Related]
33. High-throughput, sensitive quantification of repopulating hematopoietic stem cell clones.
Kim S; Kim N; Presson AP; An DS; Mao SH; Bonifacino AC; Donahue RE; Chow SA; Chen IS
J Virol; 2010 Nov; 84(22):11771-80. PubMed ID: 20844053
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive genomic access to vector integration in clinical gene therapy.
Gabriel R; Eckenberg R; Paruzynski A; Bartholomae CC; Nowrouzi A; Arens A; Howe SJ; Recchia A; Cattoglio C; Wang W; Faber K; Schwarzwaelder K; Kirsten R; Deichmann A; Ball CR; Balaggan KS; Yáñez-Muñoz RJ; Ali RR; Gaspar HB; Biasco L; Aiuti A; Cesana D; Montini E; Naldini L; Cohen-Haguenauer O; Mavilio F; Thrasher AJ; Glimm H; von Kalle C; Saurin W; Schmidt M
Nat Med; 2009 Dec; 15(12):1431-6. PubMed ID: 19966782
[TBL] [Abstract][Full Text] [Related]
35. An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses.
Wells DW; Guo S; Shao W; Bale MJ; Coffin JM; Hughes SH; Wu X
BMC Genomics; 2020 Mar; 21(1):216. PubMed ID: 32151239
[TBL] [Abstract][Full Text] [Related]
36. Genetic screens in mammalian cells by enhanced retroviral mutagens.
Liu D; Yang X; Yang D; Songyang Z
Oncogene; 2000 Dec; 19(52):5964-72. PubMed ID: 11146547
[TBL] [Abstract][Full Text] [Related]
37. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
[TBL] [Abstract][Full Text] [Related]
38. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
39. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.
Themis M; May D; Coutelle C; Newbold RF
Gene Ther; 2003 Sep; 10(19):1703-11. PubMed ID: 12923569
[TBL] [Abstract][Full Text] [Related]
40. Integration of retroviral vectors.
Gabriel R; Schmidt M; von Kalle C
Curr Opin Immunol; 2012 Oct; 24(5):592-7. PubMed ID: 22981243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
